Companies in #Orbital Inflammation
Found 1 company operating in this sector.
Ethyreal
PrivateEthyreal is a private clinical-stage biotechnology company developing antibody-based therapies for autoimmune endocrine disorders, with a focus on Graves' disease and the related thyroid eye disease (TED). Its lead candidate selectively targets the IGF-1 receptor pathway in orbital fibroblasts.